Julian Swatler

8PUBLICATIONS
72CO-AUTHORS
Innate immunityNeural engineeringCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 13, 2026
IL1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma.

Andrea Mariancini, Domenico Supino, Sarah Mapelli

|Jan 16, 2026
Chitinase-3-like protein 1 depletion in glioma cells alters tumor microenvironment and normalizes neovasculature in human glioma xenografts.

Salwador Cyranowski, Małgorzata Zawadzka, Mitrajit Ghosh

|Jul 29, 2025
Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity.

Sharanya K M Wijesinghe, Lisa Rausch, Sarah S Gabriel

|Apr 02, 2024
CD4+ Regulatory T Cells in Human Cancer: Subsets, Origin, and Molecular Regulation.

Julian Swatler, Marco De Luca, Ivano Rotella

|Feb 07, 2022
4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells.

Julian Swatler, Laura Turos-Korgul, Marta Brewinska-Olchowik

|Apr 03, 2021
Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias.

Julian Swatler, Laura Turos-Korgul, Ewa Kozlowska

Pageof 2